Apyx Medical Corporation (APYX)
NASDAQ · Healthcare
Apyx Medical Corporation EBITDA 2009–2025
Apyx Medical Corporation annual/quarterly ebitda history and growth rate from 2009 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Apyx Medical Corporation ebitda for the quarter ending March 31, 2026 was -709000, a 75.66% decrease year-over-year.
- Apyx Medical Corporation ebitda for the twelve months ending March 31, 2026 was -15.5 M, a 32.60% decrease year-over-year.
- Apyx Medical Corporation annual ebitda for 2025 was -5.8 M, a 68.26% decrease from 2024.
- Apyx Medical Corporation annual ebitda for 2024 was -18.2 M, a 10.13% increase from 2023.
- Apyx Medical Corporation annual ebitda for 2023 was -16.6 M, a 26.93% decrease from 2022.
- Apyx Medical Corporation annual ebitda for 2022 was -22.7 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Apyx Medical Corporation EBITDA — FAQ
Apyx Medical Corporation (APYX) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see APYX's ebitda history?
The chart and table above show Apyx Medical Corporation's ebitda by year and by quarter, including the growth rate.